This measure is a translation of the recommendations of ICHOM for optimum IBD patient follow-up using an appropriate patient reported outcome (PRO) instrument to to measure symptoms and activities of daily living. IBD-Control is such an instrument, available without license or fees provided the original paper is cited in any publication (see Bodger, et al, Gut 2014;63(7):1092-102). This measure requires that adequate disease control is demonstrated.